ROCKVILLE, Md., Sept. 9 /PRNewswire/ -- RRD International, a strategy-driven biotech and pharmaceutical product development company, announced today that they have moved to expanded offices this month. The new office space, located at 7361 Calhoun Place, Rockville, MD, recently completed build-out and more than doubles RRD's business footprint to 13,000 sq ft.
"This move is symbolic of the growth and success RRD has achieved in the last year," said Scott Tarrant, Chief Business Officer, RRD International. "Our model has proven time and again to be more efficient and successful than traditional methods, and the market's increasing demand for RRD services necessitated finding a new space to accommodate our growing needs."
RRD International delivers tactical, regulatory-driven product development support to companies and investors in the life sciences industry. Leveraging its in-house strategic and operational expertise, the Company helps clients better plan, manage and execute product development. Having successfully completed more than 80 product development engagements with a wide range of organizations, RRD International's fully integrated development team works to enable rapid proof of concept, reduce costs, and accelerate value creation.
"Times of growth and change are always exciting," added Chuck Finn, President and CEO, RRD International. "We're thrilled to have found a place that lets us remain in Rockville and better serve our clients and partners."
About RRD International
Founded in 2002, RRD is a strategy-driven product development company. The Company's development model enables rapid proof of concept for biotech and pharmaceutical clients to accelerate value inflection points; reduce costs; and mitigate development as well as execution risk. RRD offers two distinct types of client engagements: TacDev® and DevCo®. The TacDev® model adds development bandwidth and expertise for defined
|SOURCE RRD International|
Copyright©2010 PR Newswire.
All rights reserved